Cholesterol Conversations ASCVD Management: Making the Case for Nonstatin Therapies
8 snips
Feb 21, 2023 Join Drs. Neha Pagidipati, Christie Ballantyne, and Gregory Piazza in a lively discussion on ASCVD management, including nonstatin therapies, challenges in patient care, and alternative treatment options. Explore the evolution towards combination therapy, considerations for statin-intolerant patients, and the importance of personalized treatment plans. Delve into the efficacy and tolerability of PCSK9 inhibitors and azetamide for statin-hesitant patients, and the benefits of combining medications to lower LDL cholesterol effectively in high-risk patients.
AI Snips
Chapters
Transcript
Episode notes
Shared Responsibility in Statin Management
- Explain to patients that managing high cholesterol is a long-term commitment.
- Work together with patients to find a statin dosage they can tolerate.
Addressing Statin Hesitancy
- Many patients are statin-hesitant due to perceived side effects.
- Educating patients about the true risks and benefits of statins is crucial.
Combination Therapy for LDL Lowering
- Don't give up if a patient can't tolerate high-dose statins.
- Explore combination therapies to achieve LDL targets.